Abattis Bioceuticals Corp. (ATTBF)
ATTBF Stock Price Chart
Explore Abattis Bioceuticals Corp. interactive price chart. Choose custom timeframes to analyze ATTBF price movements and trends.
ATTBF Company Profile
Discover essential business fundamentals and corporate details for Abattis Bioceuticals Corp. (ATTBF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
29 May 2014
Employees
—
Website
https://www.abattis.comCEO
Francesco Paolini
Description
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
ATTBF Financial Timeline
Browse a chronological timeline of Abattis Bioceuticals Corp. corporate events including earnings releases, dividend announcements, and stock splits.
ATTBF Stock Performance
Access detailed ATTBF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.